Substance / Medication

Insulin glulisine

Overview

Active Ingredient
insulin glulisine, human
RxNorm CUI
400008

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

948 trials linked to this intervention

948
Total Trials
110
Recruiting
300
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?
Kordonouri Olga, Biester Torben, Weidemann Jürgen et al. · Pediatr Diabetes · 2020
PMID: 32738019RCT
Efficacy of adding once-daily insulin glulisine in Japanese type 2 diabetes patients treated with insulin glargine and sitagliptin.
Takahara Mitsuyoshi, Shiraiwa Toshihiko, Katakami Naoto et al. · Diabetes Technol Ther · 2014
PMID: 24949654RCT
Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.
Hohberg Clothilde, Forst Thomas, Larbig Martin et al. · Diabetes Care · 2008
PMID: 18268067RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Insulin glulisine (substance)
SNOMED CT
411530000
UMLS CUI
C1313386
RxNorm CUI
400008

Clinical Data

This intervention maps to 13 entities in the Ltrl knowledge graph.

4
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
948
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.